Clinical Trial to Demonstrate the Effectiveness of Fecal Microbiota Transplantation for Selective Intestinal Decolonization of Patients Colonized by Carbapenemase-producing Klebsiella Pneumoniae

PHASE2TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

October 4, 2021

Primary Completion Date

November 24, 2023

Study Completion Date

November 24, 2023

Conditions
Carbapenemase-producing Enterobacteriaceae Infection
Interventions
BIOLOGICAL

Fecal microbiota transplantation

Patients will receive four fecal microbiota transplantation (FMT) capsules. Microbiota is obtained from healthy patients.

OTHER

Placebo

Patients will receive four oral capsules containing placebo. These capsules will have the same shape, weight and colour as capsules containing FMT.

Trial Locations (1)

14004

Hospital Universitario Reina Sofía, Córdoba

All Listed Sponsors
collaborator

Mikrobiomik Healthcare Company S.L.

INDUSTRY

lead

Maimónides Biomedical Research Institute of Córdoba

OTHER